DOCSLIB.ORG

Welcome Letter

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Welcome letter Dear friends and colleagues, Organised by the Heart Failure Association of the European Society of Cardiology (HFA), the Heart Failure congress is a unique forum where cardiologists, interventional heart failure specialists, cardiac surgeons, internists, practicing general physicians, basic scientists, epidemiologists, cardiac nurses, industry affiliates and others have the opportunity to meet and exchange ideas and information. The Heart Failure congress is an international event open to healthcare professionals interested in any aspect of heart failure from epidemiology, through basic and translational science to prevention (reviewing the treatment of hypertension and post-infarction care), diagnosis (including novel imaging modalities and biomarkers), monitoring (together with remote monitoring), prognostication (risk stratification as well as use of biomarkers), medical and nursing management (including drugs, devices, tele-care and surgery). With this year’s main theme, ‘Heart Failure from Alpha to Omega’, the congress incorporates interactive sessions, hands-on or meet the expert sessions, and also provide the tools to apply and interpret the latest scientific and clinical expertise to empower the day-to-day work of heart failure specialists today. The congress will maintain its position as the most important platform for scientific exchange and networking in heart failure worldwide. Thank you for being with us in Athens! Gerasimos Filippatos Petar Seferovic Heart Failure 2019 HFA President Scientific Chairperson (2018-2020) 1 D8614-FP-HF2019_01-Gen-Info_v4.indd 1 16/04/2019 16:39 Heart Failure 2019 Committees HEART FAILURE ASSOCIATION - BOARD MEMBERS 2018-2020 Prof. Petar M. Seferovic (RS) Prof. Yuri Lopatin (RU) HFA President Coordinator for National Heart Failure Societies and Working Groups Prof. Frank Ruschitzka (CH) HFA Past President Prof. Stephane Heymans (NL) Chairperson of the Basic Science Section Prof. Andrew Coats (UK) HFA President-Elect Prof. Johann Bauersachs (DE) Chairperson of the Clinical Section Prof. Giuseppe Rosano (UK) Treasurer Associate Prof. Mitja Lainscak (SI) Secretary CLINICAL SECTION Dr. Tuvia Ben Gal (IL) Prof. Lars Lund (SE) Prof. Jelena Celutkiene (LT) Prof. Davor Milicic (HR) Dr. Ovidiu Chioncel (RO) Dr. Brenda Moura (PT) Dr. Loreena Hill (UK) Prof. Christian Mueller (CH) Prof. Tiny Jaarsma (SE) Prof. Wilfried Mullens (BE) Prof. Ewa Jankowska (PL) Dr. Maurizio Volterrani (IT) BASIC SCIENCE SECTION Prof. Johannes Backs (DE) Prof. Rudolf De Boer (NL) Dr. Alexander Lyon (UK) EX-OFFICIO Prof. Gerasimos Filippatos (GR) Prof. Marco Metra (IT) Chair, Scientific Programme Committee Editor in Chief, Heart Failure 2019 European Journal of Heart Failure Prof. Thomas Thum (DE) Prof. Stefan D. Anker (DE) Chair, WG on Myocardial Function Editor in Chief, ESC Heart Failure SUI GENERIS Prof. Massimo Piepoli (IT) Prof. Piotr Ponikowski (PL) 2 D8614-FP-HF2019_01-Gen-Info_v4.indd 2 16/04/2019 16:39 Gold, Silver and Regular Heart failure specialists of Tomorrow (HoT) Fellows of the HFA European Journal of Heart Failure Impact Factor: 10.683 Open access journal: ESC Heart Failure Position Papers Advocacy HFA Atlas 50 National Heart Failure Societies & Working Groups 30 countries participating in Awareness Days heartfailurematters.org Heart Failure Congress HFA Winter Meeting on Translational Heart Failure Research E-Learning & Webinars Curricula and Certification Postgraduate Course in Heart Failure Clinical Trialists Summer School Guidelines and Registries D8614-FP-HF2019_01-Gen-Info_v4.indd 3 16/04/2019 16:39 JOIN THE HEART FAILURE COMMUNITY A worldwide organisation of healthcare professionals with the same interests and goals as you Latest scientific information Networking Career Education Become a member Development at the HFA / ESC stand Get more Combine HFA Silver Membership with ESC Professional Membership to access more discounts and learning opportunities. www.escardio.org/HFA-membership D8614-FP-HF2019_01-Gen-Info_v4.indd 4 16/04/2019 16:39 Practical information CERTIFICATES For attendance – available from the registration desks as of Monday 27 May midday. For presentation – available for abstract presenters at the poster assistance desk in the poster area INTERNET CONNECTION Free wifi is available at the congress centre. However please note that connectivity is subject to the volume of users. Wifi name: hf-congress Wifi password: hf-congress Computer with internet access are located in the exhibition. INFO POINTS For any other information, please address the organisers at the registration. SECURITY Please ensure your badge is visible at all times and comply with security controls that you may be subject to within the congress venue. CHILDCARE SERVICE To ensure equal access to education opportunities, we are pleased to offer, via our partner, a limited childcare service onsite staffed by approved childcare providers. Childcare service is located in a hotel close to the venue (5mn walk). If you would like to take advantage of this service, please register directly at the hotel (free service, first come first served basis): The Golden Age Hotel of Athens, Room Kalypso Michalakopoulou 57, Athens 115 28 Greece HFA MEMBERS’ LOUNGE The lounge is an exclusive area located above the exhibition where Gold Members and Fellows of the HFA are invited to enjoy breaks and refreshments. Become a member at the HFA / ESC stand 5 D8614-FP-HF2019_01-Gen-Info_v4.indd 5 16/04/2019 16:39 Don’t Miss Highlights at Heart Failure 2019 • HFA Grand Debates: the most popular controversies in the management of heart failure will be debated by specialists, who will defend their arguments in front of their opponent and a panel of world renowned experts. • Off the record with experts: everything you’ve always wanted to know but never dared to ask! These sessions will open the floor to an informal discussion with world renowned experts on topics relevant to your career. Special tracks at Heart Failure 2019 • Guidelines into Practice: this track will focus on how to implement the ESC Guidelines into routine management of cardiovascular patients. Based on real clinical cases, these sessions will provide you with the tools to improve your daily practice. • World Congress on Acute Heart Failure: an extensive offer of symposia, How-To sessions, debates, educational sessions, late breaking trials and abstract sessions. • Basic Science: a full programme dedicated to basic science includes ten sessions in the room Ljubljana, the Young Investigator Award session in Basic Science, oral abstract sessions and dedicated poster sessions. Special events at Heart Failure 2019 • Inaugural session including the HFA Eugene Braunwald and the HFA Philip Poole Wilson Lectures on Saturday 25 May, 17.45-19.15 Room Trianti. • HFA Career Cafe: in a relaxed atmosphere, with a cup of coffee or tea, young heart failure enthusiasts will be given the opportunity to meet internationally renowned experts in the field. Pre-registration was needed: stay tuned for next year’s event! • Virtual Case Area: experience real-life clinical cases on a virtual patient simulator, located Level 0 on your way to Room Mitropoulos everyday during coffee breaks. • CPR Workshops: Register for free for the CPR Workshops. Seats are limited. A dedicated desk on-site will be available in front of the CPR workshop area, located Level 1, in front of Room Lambrakis from Saturday afternoon to Monday afternoon in parallel to scientific sessions. 6 D8614-FP-HF2019_01-Gen-Info_v4.indd 6 16/04/2019 16:39 • HOT Walk: public event organised by the Hellenic Society of Cardiology with the support of the Heart failure Specialists of Tomorrow (HoT - HFA young Communitty). Rendez-vous on Monday at 18:00 in front of the Congress Center for a 3.5 km walk Special sessions • Late Breaking Science: presenters will share the very latest results of their research. The presentations will be concluded by a review from an expert. Be there to hear about the latest developments in heart failure. • Award sessions: four award sessions at the congress will feature the best abstracts in the field - Young Investigator Awards Clinical & Basic Science, Nursing Investigator Awards and Clinical Case Awards. • The year’s best papers on heart failure: this session will review the best papers published throughout the year between three major journals in the field: the European Journal of Heart Failure, the European Heart Journal and ESC Heart Failure. • HFA Focus: clinical case-based interactive sessions that will provide clear take-home messages for you to use in your daily practice. • Heart Failure 2019 Highlights: Experts summarise, by topic, the best findings of the congress. Attend this session to get an overview of the entire congress. 7 D8614-FP-HF2019_01-Gen-Info_v4.indd 7 16/04/2019 16:39 Download Heart Failure Mobile App Latest messages Sessions by day, topic, type or track Vote & Ask questions during mobile app interactive sessions Personalised programme Exhibitors’ details & onsite practical info Search for ‘ESC Congresses’ or ‘Heart Failure’ in App Store® / Google Play. Heart Failure 2019 is now a part of ESC Congresses app. Scientific Resources Select the presentation of interest and click on: ‘View full abstract’ or ‘Access slides & videos online’ D8614-FP-HF2019_01-Gen-Info_v4.indd 8 16/04/2019 16:39 Industry @HF 2019 Acknowledgement The Heart Failure Association expresses its sincere appreciation to all exhibitors, industry partners and sponsors mentioned below, who have contributed
Recommended publications
  • G2 Phase Cell Cycle Regulation by E2F4 Following Genotoxic Stress

    G2 Phase Cell Cycle Regulation by E2F4 Following Genotoxic Stress

    G2 Phase Cell Cycle Regulation by E2F4 Following Genotoxic Stress by MEREDITH ELLEN CROSBY Submitted in partial fulfillment of the requirements for the Degree of Doctor of Philosophy Thesis Advisor: Dr. Alex Almasan Department of Environmental Health Sciences CASE WESTERN RESERVE UNIVERSITY May, 2006 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ______________________________________________________ candidate for the Ph.D. degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. TABLE OF CONTENTS TABLE OF CONTENTS………………………………………………………………….1 LIST OF FIGURES……………………………………………………………………….5 LIST OF TABLES………………………………………………………………………...7 ACKNOWLEDGEMENTS……………………………………………………………….8 LIST OF ABBREVIATIONS……………………………………………………………10 ABSTRACT……………………………………………………………………………...15 CHAPTER 1. INTRODUCTION 1.1. CELL CYCLE REGULATION: HISTORICAL OVERVIEW………………...17 1.2. THE E2F FAMILY OF TRANSCRIPTION FACTORS……………………….22 1.3. E2F AND CELL CYCLE CONTROL 1.3.1. G0/G1 Phase Transition………………………………………………….28 1.3.2. S Phase…………………………………………………………………...28 1.3.3. G2/M Phase Transition…………………………………………………..30 1.4.
  • Individual Index

    Individual Index

    INDIVIDUAL INDEX Bl Page Page A Cooremans-Cruz, Eugenio Juan 3825 Cortes, Eugenia 2474 Abbott, Charles P 3807 Crowley, Daniel 3820 Abrams, Samuel S 3825 Cruz, Marinelle Khristy 3836 Abshire, Arthur J 3812 Cuervo, Ester 3825 Ah Kwang Chang 3827 Cuffy, Jackson Ormiston Edwards and Ah Sing Ying 3826 Merle Cleopatra Edwards 38J54 Ah Young Cho Kwak 3803 Alcala-Salcedo, Apolinario 3825 D Alvarado, Irma Victoria Bolarte 3853 Araujo,Lilia 3828 D'Souza, Eustace John 3824 Araujo, Maria Freitas 3825 Datronics Engineers, Inc 3857 Arellano, Santos Marquez 3830 Daves, Gary 3862 Armstrong, Anne L 235 Davies, Mrs. Olive M.V.T., Samira Arriola, Rodolfo N 3851 D.K., Ola-Tomi K., Ola-Yinka K., Asencio-Placencio, Pedro 3825 Ilesha E.K., and Baba-Tunji K 3803 Atherley, Juana Todd 3829 Davis, Jefferson F 1304 Austin, John P 234 Day, Craig 3824 DeBravo, Cenovia Mesa 3825 B DeLuna-Segovia, Jose 3825 Dibben, James William 3823 Bader, Louis William 3825 Din, Ruben P 3831 Baglieri, George 3825 Do Sook Park 3841 Bakierowska, Kazimiera 3827 Dom Min Lee 3826 Bally, George Ally 3827 Dowd, Kazuko Nishioka 3820 Barengo, Bernardino 2485 Barrera-Cabrera, Jesus 3825 Batavia Turf Farms, Inc 3818 • ^- • E Benney, Donna Marainne 3836 Eaker, Lt. Gen. IraC 1060 Berger, Harry 3825 Eha,Elmar 3825 Binabise, Juanita 3840 Ehard,Karin 3858 Birely, Victor M 1643 Elder, William J 3814 Blakeley, Hildegard G 3845 Emde, Noel Abueg 3837 Blanquicett, Carmen Cecilia 3859 Encomienda, Rogelio M 3853 Bonderenko, Edward J 2485 Espenueva, Edmundo Alfredo Boone, Master Sgt. William E 3813 Oreiro
  • Obituaries Buffalo News 2010 by Name

    Obituaries Buffalo News 2010 by Name

    Obituaries as found in the Buffalo News: 2010 Date of Place of Date, Page of Last Name/Maiden First Name M.I. Age Death Death/Birth/Residence Date, Page detailed obit Abbarno Vincent "Lolly" A. 9/26/2010 Kenmore, NY 9-30-2010: C4 Abbatte/Saunders Murielle A. 87 1/11/2010 1-13-2010: B4 Abbo Joseph D. 57 5/31/2010 Lewiston, NY 6-3-2010: B4 Brooksville, FL; formerly of Abbott Casimer "Casey" 12/19/22009 Cheektowaga, NY 4-18-2010: C6 Abbott Phillip C. 3/31/2010 4-3-2010: B4 Abbott Stephen E. 7/6/2010 7-8-2010: B4 Abbott/Pfoetsch Barbara J. 4/20/2010 5-2-2010: B4 Abeles Esther 95 1/31/2010 2-4-2010: C4 Abelson Gerald A. 82 2/1/2010 Buffalo, NY 2-3-2010: B4 Abraham Frank J. 94 3/21/2010 3-23-2010: B4 Abrahams/Gichtin Sonia 2/10/2010 died in California 2-14-2010: C4 Abramo Rafeala 93 12/16/2010 12-19-2010: C4 Abrams Charlotte 4/6/2010 4-8-2010: B4 Abrams S. "Michelle" M. 37 5/21/2010 Salamanca, NY 5-23-2010: B4 Abrams Walter I. 5/15/2010 Basom, NY 5-19-2010: B4 Abrosette/Aksterowicz Sister Mary 6/18/2010 6-19-2010: C4 Refer to BEN 2-21-2010: B6/7/8 for more possible Abshagen Charles, Jr. L. 73 2/19/2010 North Tonawanda, NY 2-22-2010: B8 information Acevedo Miguel A. 10/6/2010 Buffalo, NY 10-27-2010: B4 Achkar John E.
  • Men Final Entries

    Men Final Entries

    Final Entries - Athletes List by event European Athletics Indoor Championships 2021, Torun/POL Tot. Number of countries Tot. Number of athletes Tot. Number of Men Tot. Number of Women 47 733 405 328 FINAL ENTRIES - Men 60m Senior Men Num. of countries: 33 Num. of athletes: 71 Member Federation Surname First Name DoB PB SB ARM Donigian Alexander 20/10/1993 6.64i 6.79i ART Keletela Dorian Celeste 06/02/1999 6.79i 6.85i AUT Fuchs Markus 14/11/1995 6.62i 6.69i BEL Kuba Di-Vita Gaylord 17/11/1995 6.73i 6.75i BEL Vleminckx Kobe 31/05/1998 6.65i 6.65i BLR Bliznets Dzianis 12/03/1995 6.75i 6.75i BLR Bohdan Maksim 19/03/1997 6.77i 6.77i BLR Zabalotny Yury 24/02/1997 6.72i 6.72i BUL Dimitrov Denis 10/02/1994 6.65i 6.73i BUL Jivkov Vesselin 26/01/2001 6.76i 6.80i CZE Hampl Štěpán 10/11/1999 6.70i 6.70i CZE Stromšík Zdeněk 25/11/1994 6.60i 6.68i CZE Veleba Jan 06/12/1986 6.65i 6.65i DEN Hansen Simon 30/06/1998 6.75i 6.75i DEN Kjær Emil Mader 20/12/1999 6.77i 6.77i DEN Musah Kojo 15/04/1996 6.61i 6.61i ESP López Sergio 05/07/1999 6.67i 6.74i ESP Rodríguez Daniel 26/01/1995 6.67i 6.67i ESP Sanchez Ricardo 10/08/1999 6.75i 6.75i EST Nazarov Karl Erik 17/03/1999 6.63i 6.63i FIN Illukka Riku 21/09/1999 6.73i 6.73i FIN Purola Samuel 19/05/2000 6.67i 6.67i FIN Samuelsson Samuli 23/06/1995 6.66i 6.66i FRA Fall Mouhamadou 25/02/1992 6.62i 6.62i FRA Golitin Amaury 28/01/1997 6.62i 6.62i GBR Aikines-Aryeetey Harry 29/08/1988 6.55i 6.67i GBR Bromby Oliver 30/03/1998 6.63i 6.65i GBR Robertson Andrew 17/12/1990 6.54i 6.61i GER Corucle Philipp 18/07/1997 6.62i
  • THE NAMES LIST Version 7.2 -.:: GEOCITIES.Ws

    THE NAMES LIST Version 7.2 -.:: GEOCITIES.Ws

    List of Names, Vers. 7.2 THE NAMES LIST Version 7.2 We apologize if any names are misspelled, misplaced or in any other way misused – we can’t know everything! Shorter versions and/or nicknames are listed as Name (Short version) Some names are listed with their meaning in English as Name=english word All firstnames marked with an * are rather old-fashioned and not common among younger people any more. The surnames marked with an ** are names of prominent persons which are actually very rare. CONTEMPORARY NAMES (Bear in mind that several countries, China to name one, list surnames/family names before firstnames/personal names!) Song Abdullah African Surnames Songo’O Achmed Tchami Ahmet Adepoju Tchango Akif Amokachi Tchoutang Ali Amunike Tinkler Arif Andem Tovey Aykut Angibeaud Bahri Ardense Bekir Babayaro Arabian Female Firstnames Bülent Baruwa Aynur Durmus Billong Ayse Dursun Dosu Aysel Erdal Ekoku Belkis Erkan Etamé Berna Erol Finidi Cigdem Fahri Foe Damla Gazi Ikpeba Demet Halifi Ipoua Derya Halil Issa Dilek Hamza Kalla Elif Hassan Kanu Elo Hüsein Khumaleo Fahrie Iskender Kipketer Fatima Ismail Lobé Fatma Ismet M’butu Fehime Khalib Mapela Gulizar Khaled Masinga Gülcan Leyla Mboma Hacer Mehmet Mimboe Hatice Yusuf Moeti Hazel Zeki Moshoeu Hediye Ziya Motaung Hüeyla Moukoko Makbule Obafemi Medine Arabian Surnames Ohenen Mürüret Al - Okechukwu Nazli Okocha Shahrzad Abedzadeh Okpara Tanzu Al Awad Olembé Al Daeya Oliseh Arabian Male Firstnames Al Dokhy Opakuru Al Dossari Abdul Redebe Al Dossary Compiled By Krikkit Gamblers Page 1 List of Names,
  • Durham E-Theses

    Durham E-Theses

    Durham E-Theses Elemental Fluorine for the Greener Synthesis of Life-Science Building Blocks HARSANYI, ANTAL How to cite: HARSANYI, ANTAL (2016) Elemental Fluorine for the Greener Synthesis of Life-Science Building Blocks, Durham theses, Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/11705/ Use policy The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that: • a full bibliographic reference is made to the original source • a link is made to the metadata record in Durham E-Theses • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders. Please consult the full Durham E-Theses policy for further details. Academic Support Oce, Durham University, University Oce, Old Elvet, Durham DH1 3HP e-mail: [email protected] Tel: +44 0191 334 6107 http://etheses.dur.ac.uk 2 Durham University A thesis entitled Elemental Fluorine for the Greener Synthesis of Life-Science Building Blocks by Antal Harsanyi (College of St. Hild and St. Bede) A candidate for the degree of Doctor of Philosophy Department of Chemistry, Durham University 2016 Antal Harsanyi: Elemental fluorine for the greener synthesis of life-science building blocks Abstract Fluorinated organic compounds are increasingly important in many areas of our modern lives, especially in pharmaceutical and agrochemical applications where the incorporation of this element can have a major influence on biochemical properties.
  • 2013 Kaiser Permanente-Authored Publications Alphabetical by Author

    2013 Kaiser Permanente-Authored Publications Alphabetical by Author

    2013 Kaiser Permanente-Authored Publications Alphabetical by Author 1. Abbas MA, Cannom RR, Chiu VY, Burchette RJ, Radner GW, Haigh PI, Etzioni DA Triage of patients with acute diverticulitis: are some inpatients candidates for outpatient treatment? Colorectal Dis. 2013 Apr;15(4):451-7. Southern California 23061533 KP author(s): Abbas, Maher A; Chiu, Vicki Y; Burchette, Raoul J; Radner, Gary W; Haigh, Philip I 2. Abbass MA, Slezak JM, DiFronzo LA Predictors of Early Postoperative Outcomes in 375 Consecutive Hepatectomies: A Single- institution Experience Am Surg. 2013 Oct;79(10):961-7. Southern California 24160779 KP author(s): Abbass, Mohammad Ali; Slezak, Jeffrey M; DiFronzo, Andrew L 3. Abbenhardt C, Poole EM, Kulmacz RJ, Xiao L, Curtin K, Galbraith RL, Duggan D, Hsu L, Makar KW, Caan BJ, Koepl L, Owen RW, Scherer D, Carlson CS, Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) and CCFR, Potter JD, Slattery ML, Ulrich CM Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia Int J Mol Epidemiol Genet. 2013 Sep 12;4(3):140-9. Northern California 24046806 KP author(s): Caan, Bette 4. Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America Clin Infect Dis. 2013 Nov 13. Mid-Atlantic 24235263 KP author(s): Horberg, Michael 5. Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, Moore RD, Klein MB, Kitahata MM, Kirk GD, Hogg RS, Hessol NA, Goedert JJ, Gill MJ, Gebo KA, Eron JJ, Engels EA, Dubrow R, Crane HM, Brooks JT, Bosch RJ, Strickler HD, North American AIDS Cohort Collaboration on Research and Design of IeDEA Invasive cervical cancer risk among HIV-infected women: A North American multi-cohort collaboration prospective study J Acquir Immune Defic Syndr.
  • World Ratings Draughts

    World Ratings Draughts

    FMJD Rating No 83 January/March 2015 FMJD rating Nr 83 January 2015 email: [email protected] 1 FMJD Rating No 83 January/March 2015 With any question concerning this issue You can contact me directly via email: [email protected] 2 FMJD Rating No 83 January/March 2015 1. Rating - open Name Nationality Title Rating +/- 1 = shvartsman alexander Russia gmi 2425 -19 2 = georgiev alexander Russia gmi 2421 -15 3 +5 chizhov alexey Russia gmi 2409 +18 4 = getmanski alexander Russia gmi 2404 +4 5 +1 boomstra roel Netherlands gmi 2399 +4 6 -3 baliakin alexander Netherlands gmi 2396 -11 7 = gantvarg anatoli Belarus gmi 2393 +1 8 -3 valneris guntis Latvia gmi 2388 -9 9 +2 prosman erno Netherlands gmi 2378 +2 10 +2 dolfing martin Netherlands gmi 2377 +3 11 +3 shaibakov ainur Russia gmi 2373 +6 12 -2 virny vadim Germany gmi 2370 -7 13 +3 amrillaev murodullo Russia gmi 2367 +3 14 -5 meurs pim Netherlands gmi 2364 -16 15 = clerc rob Netherlands gmi 2363 -3 16 -3 ivanov artem Ukraine mi 2361 -11 17 +2 cordier arnaud France gmi 2358 +7 18 -1 ndjofang jean marc Cameroon gmi 2357 +4 19 +3 heusdens ron Netherlands gmi 2351 +3 20 +4 jansen gerard Netherlands gmi 2348 +3 21 +7 kalmakov andrej Russia gmi 2346 +5 22 +1 vermin hans Switzerland gmi 2346 = 23 -2 n'diaye macodou Senegal gmi 2344 -5 24 +5 anikeev yuriy Ukraine gmi 2343 +5 25 -7 krajenbrink johan Netherlands gmi 2341 -11 26 +1 van den akker jeroen Netherlands gmi 2339 -3 27 +3 leesmann kaido Estonia gmi 2337 = 28 +3 misans roberts Latvia mi 2336 = 29 +3 kolesov gawril Russia mi 2334 = 30 -4 vatutin evgeni
  • Merck Announces U.S. FDA Approval of VERQUVO® (Vericiguat)

    Merck Announces U.S. FDA Approval of VERQUVO® (Vericiguat)

    NEWS RELEASE Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat) 1/20/2021 VERQUVO Approved for Reduction of Risk of Cardiovascular Death and Heart Failure (HF) Hospitalization Following a Hospitalization for HF or Need for Outpatient Intravenous (IV) Diuretics in Adults with Symptomatic Chronic Heart Failure and Ejection Fraction Less than 45% VERQUVO is the First Soluble Guanylate Cyclase Stimulator, Approved to Treat Heart Failure KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved VERQUVO, a soluble guanylate cyclase (sGC) stimulator, to reduce the risk of cardiovascular death and heart failure hospitalization following a hospitalization for heart failure or need for outpatient intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. The approval of VERQUVO by the FDA, which is the rst treatment for chronic heart failure approved specically for patients following a hospitalization for heart failure or need for outpatient IV diuretics, is based on the results of the pivotal Phase 3 VICTORIA trial and follows a priority regulatory review. VERQUVO (vericiguat) 2.5 mg, 5 mg, and 10 mg tablets is being jointly developed with Bayer AG. The VERQUVO label contains a boxed warning that indicates that VERQUVO should not be administered to pregnant females because it may cause fetal harm. For more information, see “Selected Safety Information” below. “Patients with symptomatic chronic heart failure and reduced ejection fraction have a high risk for hospitalization after experiencing symptoms of heart failure requiring outpatient IV diuretic treatment or hospitalization.
  • Treatment of Children with Pulmonary Hypertension. Expert Consensus Statement on the Diagnosis and Treatment of Paediatric Pulmonary Hypertension

    Treatment of Children with Pulmonary Hypertension. Expert Consensus Statement on the Diagnosis and Treatment of Paediatric Pulmonary Hypertension

    Pulmonary vascular disease ORIGINAL ARTICLE Heart: first published as 10.1136/heartjnl-2015-309103 on 6 April 2016. Downloaded from Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK Georg Hansmann,1 Christian Apitz2 For numbered affiliations see ABSTRACT administration (oral, inhaled, subcutaneous and end of article. Treatment of children and adults with pulmonary intravenous). Additional drugs are expected in the Correspondence to hypertension (PH) with or without cardiac dysfunction near future. Modern drug therapy improves the Prof. Dr. Georg Hansmann, has improved in the last two decades. The so-called symptoms of PAH patients and slows down the FESC, FAHA, Department of pulmonary arterial hypertension (PAH)-specific rates of clinical deterioration. However, emerging Paediatric Cardiology and medications currently approved for therapy of adults with therapeutic strategies for adult PAH, such as Critical Care, Hannover PAH target three major pathways (endothelin, nitric upfront oral combination therapy, have not been Medical School, Carl-Neuberg- fi Str. 1, Hannover 30625, oxide, prostacyclin). Moreover, some PH centres may use suf ciently studied in children. Moreover, the com- Germany; off-label drugs for compassionate use. Pulmonary plexity of pulmonary hypertensive vascular disease [email protected] hypertensive vascular disease (PHVD) in children is (PHVD) in children makes the selection of appro- complex, and selection of appropriate therapies remains priate therapies a great challenge far away from a This paper is a product of the fi writing group of the European dif cult. In addition, paediatric PAH/PHVD therapy is mere prescription of drugs.
  • World Scientists' Warning of a Climate Emergency

    World Scientists' Warning of a Climate Emergency

    Supplemental File S1 for the article “World Scientists’ Warning of a Climate Emergency” published in BioScience by William J. Ripple, Christopher Wolf, Thomas M. Newsome, Phoebe Barnard, and William R. Moomaw. Contents: List of countries with scientist signatories (page 1); List of scientist signatories (pages 1-319). List of 153 countries with scientist signatories: Albania; Algeria; American Samoa; Andorra; Argentina; Australia; Austria; Bahamas (the); Bangladesh; Barbados; Belarus; Belgium; Belize; Benin; Bolivia (Plurinational State of); Botswana; Brazil; Brunei Darussalam; Bulgaria; Burkina Faso; Cambodia; Cameroon; Canada; Cayman Islands (the); Chad; Chile; China; Colombia; Congo (the Democratic Republic of the); Congo (the); Costa Rica; Côte d’Ivoire; Croatia; Cuba; Curaçao; Cyprus; Czech Republic (the); Denmark; Dominican Republic (the); Ecuador; Egypt; El Salvador; Estonia; Ethiopia; Faroe Islands (the); Fiji; Finland; France; French Guiana; French Polynesia; Georgia; Germany; Ghana; Greece; Guam; Guatemala; Guyana; Honduras; Hong Kong; Hungary; Iceland; India; Indonesia; Iran (Islamic Republic of); Iraq; Ireland; Israel; Italy; Jamaica; Japan; Jersey; Kazakhstan; Kenya; Kiribati; Korea (the Republic of); Lao People’s Democratic Republic (the); Latvia; Lebanon; Lesotho; Liberia; Liechtenstein; Lithuania; Luxembourg; Macedonia, Republic of (the former Yugoslavia); Madagascar; Malawi; Malaysia; Mali; Malta; Martinique; Mauritius; Mexico; Micronesia (Federated States of); Moldova (the Republic of); Morocco; Mozambique; Namibia; Nepal;
  • Journal Officiel De La République Française

    Journal Officiel De La République Française

    o er Quarante-troisième année. – N 231 A ISSN 0298-296X Mardi 1 décembre 2009 BODACCBULLETIN OFFICIEL DES ANNONCES CIVILES ET COMMERCIALES ANNEXÉ AU JOURNAL OFFICIEL DE LA RÉPUBLIQUE FRANÇAISE Standard......................................... 01-40-58-75-00 DIRECTION DES JOURNAUX OFFICIELS Annonces....................................... 01-40-58-77-56 Renseignements documentaires 01-40-58-79-79 26, rue Desaix, 75727 PARIS CEDEX 15 Abonnements................................. 01-40-15-67-77 www.journal-officiel.gouv.fr (8h30à 12h30) www.bodacc.fr Télécopie........................................ 01-40-15-72-75 BODACC “A” Ventes et cessions - Créations d’établissements Procédures collectives Procédures de rétablissement personnel Avis relatifs aux successions Avis aux lecteurs Les autres catégories d’insertions sont publiées dans deux autres éditions séparées selon la répartition suivante Modifications diverses..................................... $ BODACC “B” Radiations ......................................................... # Avis de dépôt des comptes des sociétés .... BODACC “C” Banque de données BODACC servie par les sociétés : Altares-D&B, EDD, Extelia, Questel, Tessi Informatique, Jurismedia, Pouey International, Scores et Décisions, Les Echos, Creditsafe, Coface services, Cartegie, La Base Marketing, Infolegale, France Telecom Orange, Telino et Maxisoft. Conformément à l’article 4 de l’arrêté du 17 mai 1984 relatif à la constitution et à la commercialisation d’une banque de données télématique des informations contenues dans le BODACC, le droit d’accès prévu par la loi no 78-17 du 6 janvier 1978 s’exerce auprès de la Direction des Journaux officiels. Le numéro : 2,50 € Abonnement. − Un an (arrêté du 21 novembre 2008 publié au Journal officiel du 27 novembre 2008) : France : 386,20 €. Pour l’expédition par voie aérienne (outre-mer) ou pour l’étranger : paiement d’un supplément modulé selon la zone de destination ; tarif sur demande Paiement à réception de facture.